| Name | pravastatin sodium |
|---|---|
| Synonyms |
Selipran
PRAVACHOL 1-Naphthalenehtanoicacid Oliprevin Sodium (+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(S)-2-methylbutyryloxy]-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoate Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate Pravastatin sodium a HMG-CoA reductase inhibitor 2-alpha,6-alpha,8-beta(r*),8a-alpha)) Pravastatin sodium PRAVASTATIN SODIUM SALT (BET, DELT,1S,2S,6S,8S,8-1,2,6,7,8,8A-HEXAHYDRO-BETA, DELTA,6-TRIHYDROXY-2-METHYL-8[(2S)-2-METHYL-1-OXOBUTOXYL]-1-NAPHTHALENEHTANOIC ACID SODIUM (BETA R,DELTA R,1S,2S,6S,8S,8-1,2,6,7,8,8A-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-1-NAPHTHALENEHTANOIC ACID MONOSODIUM SALT PRAVASTATIN SODIUM Lipidal Pravastatine Pravastatin, Sodium Salt - - Calbiochem 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt, (βR,δR,1S,2S,6S,8S,8aR)- (1:1) 1-Naphthalenehtanoic acid, 1,2,6,7,8,8a-hexahydro-b,d,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, monosodium salt, (bR,dR,1S,2S,6S,8S,8)- (9CI) tastatin sodium salt hydrate utoxy)-beta,delta,6-trihydroxy-,monosodiumsalt,(1s-(1-alpha(beta-s*,delta-s MFCD00887601 3BETA-HYDROXYCOMPACTIN, NA tastatin sodium salt, (βR, δR,1S,2S,6S,8S,8-1,2,6,7,8,8a-Hexahydro-β, δ,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthalenehtanoic acid sodium 1-Naphthalenehtanoic acid, 1,2,6,7,8,8a-hexahydro-.beta.,.delta.,6-trihydroxy-2-methyl-8-(2S)-2-methyl-1-oxobutoxy-, monosodium salt, (.beta.R,.delta.R,1S,2S,6S,8S,8) Liprevil 3b-Hydroxycompactin Sodium Salt (βR, δR,1S,2S,6S,8S,8-1,2,6,7,8,8a-Hexahydro-β, δ,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthalenehtanoic acid sodium hydrate TASTATIN SODIUM tastatin Pravasin Pravasine [1S-[1a(bS*,dS*),2a,6a,8b(R*),8aa]]-1,2,6,7,8,8a-Hexahydro-b,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic Acid Monosodium Salt ELISOR Pravastatinesodium KOPOSTAT Pravacol Pravastatinsodium,(S) Elisor, Kopostat, Mevalotin, Pravachol, Pravaselect Pavastatin PravastatinNaC23H35Na07 Natrium-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoat Mevalotin, CS 514, SQ Pravastatin sodium, >= lipostat (R,dR,1S,2S,6S,8S,8-1,2,6,7,8,8a-Hexahydro-,d,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthalenehtanoic Acid Sodium Salt sq31000 Selektine Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthalenyl]heptanoate Vasten [1S-[1a(bS,dS),2a,6b,8b(R),8aa]]-1,2,6,7,8,8a-Hexahydro-b,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthalenehtanoic acid monosodium salt sodiuM (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8-6-hydroxy-2-Methyl-8-(((S)-2-Methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)htanoate (βr, δr,1s,2s,6s,8s,8-1,2,6,7,8,8a-hexahydro-β, δ,6-trihydroxy-2-methyl-8[(2s)-2-methyl-1-oxobutoxyl]-1-naphthalenehtanoic acid sodium (3R,5R)-7-((1S,2S,6S,8S,8-2,6-dimethyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyhtanoate [1S-[1a(bS,dS),2a,6b,8b(R),8aa]]-1,2,6,7,8,8a-Hexahydro-b,d,6-tri astatinsodium (BETA-R,DELTA-R,1S,2S,6S,8S,8-1,2,6,7,8,8A-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8[(2S)-2-METHYL-1-OXOBUTOXYL]-1-NAPHTHALENEHTANOIC ACID NA PRAVASELECT Secobbital Solution, 100ppm MEVALOTIN 3b-Hydroxycompactin sodium salt PRAVASTATIN (SODIUM) (CS-514 (SODIUM)) Prava Pravastatin sodiuM salt hydrate 1-Naphthalenehtanoic acid, 1,2,6,7,8,8a-hexahydro-b,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, [1S-[1a(bS*,dS*),2a,6a,8b(R*),8aa]] |
| Description | Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.Target: HMG-CoA reductasePravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight-loss for lowering cholesterol and preventing cardiovascular disease.Pravastatin is primarily used for the treatment of dyslipidemia and the prevention of cardiovascular disease. It is recommended to be used only after other measures such as diet, exercise, and weight reduction have not improved cholesterol levels.The evidence for the use of pravastatin is generally weaker than for other statins. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT), failed to demonstrate a difference in all-cause mortality or nonfatal myocardial infarction/fatal coronary heart disease rates between patients receiving pravastatin 40mg daily (a common starting dose) and those receiving usual care. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 634.5ºCat 760 mmHg |
|---|---|
| Melting Point | 171.2-173 °C |
| Molecular Formula | C23H35NaO7 |
| Molecular Weight | 446.51 |
| Flash Point | 213.2ºC |
| PSA | 124.29000 |
| LogP | 2.44040 |
| Storage condition | 2-8°C |
| Water Solubility | H2O: 19 mg/mL |
| Hazard Codes | F: Flammable;C: Corrosive; |
|---|---|
| Risk Phrases | R11 |
| Safety Phrases | 16-26-36/37/39-45 |
| RIDADR | 3077 |
| WGK Germany | 2 |
| RTECS | QJ7185000 |
| Packaging Group | III |
| Hazard Class | 9 |
| HS Code | 2932999099 |
|
~87%
81131-70-6 |
| Literature: BIOCON LIMITED Patent: WO2005/19155 A1, 2005 ; Location in patent: Page/Page column 8 ; |
|
~%
81131-70-6 |
| Literature: US2005/113446 A1, ; Page/Page column 6 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |